Histochemical Analysis of Glaucoma Caused by a Myocilin Mutation in a Human Donor Eye.
der Heide Carly J van, Wallace L M Alward, Miles Flamme-Wiese, Megan Riker, Nasreen A Syed, Michael G Anderson, Keith Carter, Markus H Kuehn, Edwin M Stone, Robert F Mullins, John H Fingert
Summary
This is the first histopathological analysis of an eye from a glaucoma patient with amutation.
Abstract
OBJECTIVE
Mutations in myocilin (may cause either juvenile open angle glaucoma (JOAG) or adult-onset primary open angle glaucoma (POAG).encodes a glycoprotein that is normally secreted from trabecular meshwork cells that regulate intraocular pressure. Priortransgenic rodent, and organ culture experiments have suggested that abnormal accumulation of MYOC protein within trabecular meshwork cells is a key step in glaucoma pathophysiology. We investigated the pathogenesis ofglaucoma by examining a donor eye from a patient with JOAG caused by a Tyr437Hismutation.
DESIGN
Case-control, immunohistochemical study of a donor eye from a patient with JOAG caused by a Tyr437Hismutation and age-matched control donor eyes.
SUBJECTS
An eye from a 59-year-old male with JOAG caused by a Tyr437Hismutation and eyes from five donors (ages 51-66) with no known ocular disease were examined.
METHODS
Frozen fixed sections of the iridocorneal angle were prepared from the donor eyes of theglaucoma patient and control eyes. We used antibodies directed against MYOC, collagen IV, and BiP/GRP78 as well as wheat germ agglutinin and concanavalin A lectins to localize MYOC protein in the trabecular meshwork.
MAIN OUTCOME MEASURE
Qualitative comparison of MYOC protein labeling and localization in the trabecular meshwork of donor eyes from a glaucoma patient with amutation and from control subjects.
RESULTS
Using immunohistochemistry, we detected more abundant MYOC protein within the trabecular meshwork of theglaucoma patient's eye than in control eyes. We further localized MYOC protein within the trabecular meshwork cells of theglaucoma patient's eye by co-labeling with the endoplasmic reticulum (ER) marker GRP78 (BiP). Little to no MYOC was identified within the trabecular meshwork cells of control eyes. Minimal extracellular MYOC was detected in bothglaucoma eyes and control eyes.
CONCLUSIONS
This is the first histopathological analysis of an eye from a glaucoma patient with amutation. Furthermore, this analysis supports our model of MYOC-associated glaucoma, in whichmutations cause abnormal intracellular retention of MYOC within the ER of trabecular meshwork cells as a key step towards development of glaucoma.
More by der Heide Carly J van
View full profile →Top Research in IOP & Medical Therapy
Browse all →The Complications of Myopia: A Review and Meta-Analysis.
Inflammation in Glaucoma: From the back to the front of the eye, and beyond.
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Discussion
Comments and discussion will appear here in a future update.